OCTA in Cardiovascular Disease and Healthy Controls

Recruiting N/A Interventional Study
Patients With Cardiovascular Disease Healthy Participants
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
64 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for patients with cardiovascular disease: * cardiovascular disease defined as one or more of the following: arterial hypertension, type 2 diabetes mellitus, chronic kidney disease, heart failure Inclusion Criteria for healthy individuals: * BMI 18-29.9 kg/m2 * Non-smoker * Good…
Contacts

Agnes Bosch, MD

+49 9131 8536245

agnes.bosch@uk-erlangen.de

CONTACT

Dennis Kannenkeril, MD

+49 911 80099760

CRC.M4@uk-erlangen.de

CONTACT